Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data

31 May 2002

Abstract excerpt

OBJECTIVES: The National Institute of Child Health and Human Development Fetal Cell Isolation Study (NIFTY) is a prospective, multicenter clinical project to develop non-invasive methods of prenatal diagnosis. The initial objective was to assess the utility of fetal cells in the peripheral blood of pregnant women to diagnose or screen for fetal chromosome abnormalities. METHODS: Results of fluorescence in situ...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fetal and Pediatric Neurological Disorders
Share to Genomic variations and chromosomal abnormalities
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12124698
DOI: 10.1002/pd.347

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I dataPMID 12124698Read ↗

Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidiesSemantic proximity Read ↗

Isolation of fetal DNA from nucleated erythrocytes in maternal blood.Semantic proximity Read ↗

A new marker set that identifies fetal cells in maternal circulation with high specificitySemantic proximity Read ↗

Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal SexSemantic proximity Read ↗

Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester non-invasive prenatal diagnosisSemantic proximity Read ↗

FISH Analysis of All Fetal Nucleated Cells in Maternal Whole Blood: Improved Specificity by the Use of Two Y-chromosome ProbesSemantic proximity Read ↗

Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniquesSemantic proximity Read ↗

Maternal Plasma Fetal DNA Fractions in Pregnancies with Low and High Risks for Fetal Chromosomal AneuploidiesSemantic proximity Read ↗

Noninvasive Prenatal Diagnosis of Fetal Chromosomal Aneuploidies by Maternal Plasma Nucleic Acid AnalysisSemantic proximity Read ↗

Evidence for feasibility of fetal trophoblastic cell‐based noninvasive prenatal testingSemantic proximity Read ↗

Isolating Fetal Cells From Maternal BloodSemantic proximity Read ↗

Identification of nucleated red blood cells in maternal circulation: A second step in screening for fetal aneuploidies and pregnancy complicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.